Furthermore, even in the context of deregulated Mpl activity driven by mutant Jak2 and Calr, the negative regulatory function of Mpl-Y565 is intact in MPN, albeit unable to fully normalise platelet numbers. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.